Why the study?
Are endomyocardial biopsies safe and feasible for diagnosing myocardial disease in children and adolescents?
Are endomyocardial biopsies safe and feasible for diagnosing myocardial disease in children and adolescents?
Endomyocardial biopsies are safe in older children but carry high risks in infants under one year or when performed in the left ventricle.
Supports risk stratification by age and biopsy site in pediatric EMB; leaves open need for prospective validation before broader adoption.
Today, endomyocardial biopsies in older children with suspected myocardial disease can be performed safely with a low risk of major complications and mortality, whereas the risk of complications if the biopsy is carried out in the first year of life or taken from the left ventricle remains high.
No takes yet. Share an insight, caveat, or question.
Mueller et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: